U.S. oncology company IPOs 2006-2017
Number of initial public offerings (IPOs) from oncology companies in the U.S. from 2006 to 2017*
This statistic shows the total number of initial public offerings (IPOs) from oncology companies in the U.S. from 2006 to 2017. In 2013, 14 oncology companies went public, a record high for the recorded period.
Number of initial public offerings (IPOs) from oncology companies in the U.S. from 2006 to 2017*
Source
More information
Statistics on "Health care and cyber security"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. number of IPOs for neurology companies 2006-2017
- U.S. cardiovascular company IPO financing volume 2006-2017
- U.S. number of venture capital deals for cardiovascular companies 2006-2017
- U.S. number of venture capital deals for oncology companies 2006-2017
- Money raised through U.S. neurology company IPOs 2006-2017
- U.S. cardiovascular company IPOs 2006-2017
- U.S. psychiatry company IPO financing 2006-2017
- U.S. infectious disease company IPOs 2006-2017
- U.S. psychiatry company IPOs 2006-2017
- U.S. infectious disease company IPO financing 2006-2017
- Worldwide therapeutic licensing and acquisition deals 2008-2017 by disease type
- U.S. investment for emerging therapeutic companies 2015-2016
- Global licensing and acquisitions for emerging therapeutic companies 2015-2016
- U.S. investment for emerging therapeutic companies 2008-2017
- Worldwide share of orphan drug sales by therapy category without oncology 2024
- Orphan drug sales worldwide excluding oncology by therapy category 2024
- Consumer price index (CPI) of therapeutic devices in Belgium 2014-2019
- Oncology spending in the U.S. by form and location of dispensing 2010-2015
- Oncology spending worldwide by region 2015 vs. 2020
- Cost savings from participating in phase 2 oncology master protocol
Statistics on "Health care and cyber security"
Related topics
About Statista
